featured
3 vs 6 Months of Adjuvant FOLFOX or CAPOX for High-Risk Stage II and Stage III Colon Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Three Versus Six Months Adjuvant FOLFOX or CAPOX for High Risk Stage II and Stage III Colon Cancer Patients: The Efficacy Results of Hellenic Oncology Research Group (HORG) Participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) Project
Ann. Oncol 2019 Jun 22;[EPub Ahead of Print], J Souglakos, I Boukovinas, S Kakolyris, S Xynogalos, N Ziras, A Athanasiadis, N Androulakis, A Christopoulou, M Vaslamatzis, A Ardavanis, C Emmanouilides, I Bompolaki, C Kourousis, P Makrantonakis, C Christofyllakis, E Athanasiadis, N Kentepozidis, A Karampeazis, U Katopodi, A Anagnosopoulos, G Papadopoulos, E Prinarakis, A Kalisperi, D Mavroudis, V GeorgouliasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.